Neonatal chronic lung disease in extremely immature baboons

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 4, 1999, Pages 1333-1346

  Coalson, Jacqueline J ^a,b,c,d   Winter, Vicki T ^a,b,c   Siler Khodr, Theresa ^a,b,c   Yoder, Bradley A ^a,b,c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c WILFORD HALL MEDICAL CENTER   (United States)

^d University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LUNG SURFACTANT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; CHRONIC LUNG DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOPATHOLOGY; IMMATURITY; INTRAMUSCULAR DRUG ADMINISTRATION; LUNG ALVEOLUS; LUNG CAPILLARY; LUNG DYSPLASIA; NEWBORN DISEASE; NONHUMAN; OXYGEN THERAPY; PATENT DUCTUS ARTERIOSUS; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL;

EID: 0032884166     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.4.9810071     Document Type: Article

References (58)

1. Hack, M., J. Horbar, M. Malloy, J. Tyson, E. Wright, and L. Wright. 1991. Very low birth weight outcome of National Institute of Child Health and Human Development Neonatal Network. Pediatrics 87: 587-597.
2. Horbar, J., R. Soll, J. Sutherland, U. Kotagal, A. Philip, D. Kessler, G. Little, W. Edwards, D. Vidyasagar, T. Raju, A. Jobe, M. Ikegami, M. Mullett, D. Myerberg, T. McAuliffe, and J. Lucey. 1989. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N. Engl. J. Med. 320:959-965.
3. Northway, W. H., R. C. Rosan, and D. Y. Portor. 1967. Pulmonary disease following respirator therapy of hyaline membrane disease. N. Engl. J. Med. 276:357-368.
4. Coalson, J. J., T. J. Kuehl, M. B. Escobedo, J. L. Hilliard, F. Smith, K. Meredith, D. M. Null, Jr., W. Walsh, D. Johnson, and J. L. Robotham. 1982. A baboon model of bronchopulmonary dysplasia: II. Pathologic features. Exp. Mol. Pathol. 37:335-350.
5. Escobedo, M. B., J. L. Hilliard, F. Smith, K. Meredith, D. M. Null. Jr., W. Walsh, D. Johnson, J. J. Coalson, T. J. Kuehl, and J. L. Robotham. 1982. A baboon model of bronchopulmonary dysplasia: I. Clinical features. Exp. Mol. Pathol. 37:323-334.
6. deLemos, R. A., J. J. Coalson, D. R. Gerstmann, T. J. Kuehl, and D. M. Null. 1987. Oxygen toxicity in the premature baboon with hyaline membrane disease. Am. Rev. Respir. Dis. 136:677-682.
7. Coalson, J., T. Kuehl, T. Prihoda, and R. deLemos. 1988. Diffuse alvenlar damage in the evolution of bronchopulmonary dysplasia in the baboon. Pediatr. Res. 24:357-366.
8. Coalson, J. J., D. R. Gerstmann, V. T. Winter, and R. A. deLemos. 1991. Bacterial colonization and infection studies in the premature baboon with bronchopulmonary dysplasia. Am. Rev. Respir. Dis. 144:1140-1146.
9. Coalson, J. J., R. J. King, S. Idell, V. T. Winter, D. R. Gerstmann, and R. A. deLemos. 1992. Pathophysiologic, morphometric, and biochemical studies of the premature baboon with bronchopulmonary dysplasia. Am. Rev. Respir. Dis. 145:872-881.
10. Avery, M. E., W. H. Tooley, J. G. Keller, S. Hurd, M. Bryan, R. Cotton, M. Epstein, P. Fitzhardinge, C. Hansen, T. Hansen, W. Hodson, L. James, J. Kitterman, H. Nielsen, T Poirier, W. Truog, and J.-T. Wung. 1987. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 79:26-30.
11. Palta, M., D. Gabbert, M. Weinstein, and M. Peters. 1991. Multivariate assessment of traditional risk factors for chronic lung disease in very low birth weight neonates. J. Pediatr. 119:285-292.
12. Van Marter, L., M. Pagano, E. Allred, A. Leviton, and K. Kuban. 1992. Rule of bronchopulmonary dysplasia as a function of neonatal intensive care practices. J. Pediatr. 120:938-946.
13. Parker, R., D. Lindstrom, and R. Cotton. 1992. Improved survival accounts for most, but not all, of the increase in bronchopulmonary dysplasia. Pediatrics 90:663-668.
14. Horbor, J., T. McAuliffe, S. Adler, S. Albersheim, G. Cassady, W. Edwards, R. Jones, J. Kattwindel, E. Kraybill, V. Krishnan, P. Raschko, and A. Wilkinson. 1988. Variability in 28-day outcomes for very low birthweight infants: an analysis of 11 neonatal intensive care units. Pediatrics 82:554-559.
15. Seidner, S. D. McCurnin, J. Coalson, D. Correll, and R. Castro. 1993. A new model of chronic lung injury in surfactant-treated preterm baboons delivered at very early gestations (abstract). Pediatr. Res. 33:344A.
16. Wung, J. T., A. H. Koons, J. M. Driscoll, and L. S. James. 1979. Changing incidence of bronchopulmonary dysplasia. J. Pediatr. 95:845-847.
17. Heneghan, M., R. Sosulski, und J. Baquero. 1986. Persistent pulmonary abnormalities in newborns: the changing picture of bronchopulmonary dysplasia. Pediatr. Radiol. 16:180-184.
18. Rojas, M., A. Gonzalez, and E. Bancalari. 1995. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J. Pediatr. 126:605-610.
19. Meredith, K. S., R. A. deLemos, J. J. Coalson, R. J. King, D. R. Gerstmann, R. Kumar, T. J. Kuehl, D. C. Winter, A. Taylor, R. H. Clark, and D. M. Null, Jr. 1989. The role of lung injury in the pathogenesis of hyaline membrane disease in premature baboons. J. Appl. Physiol. 66:2150-2158.
20. Hjalmarson, O., and T. Olsson. 1974. Mechanical and ventilatory parameters in healthy and diseased newborn infants. Acta Paediatr. Scand. 247(Suppl. 1):26-48.
21. Schulze, K., M. Stefanski, J. Masterson, and L. S. James. 1983. Instrumentation for the continuous measurement of gas exchange and ventilation of infants during assisted ventilation. Crit. Care Med. 11:892-896.
22. Dunnill, M. 1962. Quantitative method in the study of pulmonary pathology. Thorax 17:320-328.
23. Weibel, E. R., and D. M. Gomez. 1962. A principal for counting tissue structures on random sections. J. Appl. Physiol. 17:343-348.
24. Thurlbeck, W. 1967. The internal surface area of nonemphysematous lungs. Am. Rev. Respir. Dis. 95:765-773.
25. Aubert, J. D., P. D. Pare, J. C. Hogg, and S. Hayashi. 1997. Platelet-derived growth factor in bronchiolitis obliterans-organizing pneumonia. Am. J. Respir. Crit. Care Med. 155:676-681.
26. Weibel, E. R. 1980. Sterological Methods: Practical Methods for Biological Morphometry. Academic Press, New York, 101-161.
27. Langston, C., K. Kida, M. Reed, and W. M. Thurlbeck. 1984. Human lung growth in late gestation and in the neonate. Am. Rev. Respir. Dis. 129:607-613.
28. Erickson, A., S. de la Monte, G. Moore, and G. Hutchins. 1987. The progression of morphologic changes in bronchopulmonary dysplasia. Am. J. Pathol. 127:474-487.
29. Hislop, A., J. Wigglesworth, R. Dosai, and V. Aber. 1987. The effects of preterm delivery and mechanical ventilation on human lung growth. Early Hum. Dev. 15:147-164.
30. Chambers, H., and D. Van Velzen. 1989. Ventilator-associated pathology in the extremely immature lung. Pathology 21:79-83.
31. Margraf, L., J. Tomashefski, M. Bruce, and B. Dahms. 1991. Morphometric analysis of the lung in bronchopulmonary dysplasia. Am. Rev. Respir. Dis. 143:391-400.
32. Van Lierde, S., A. Cornelis, H. Devlieger, P. Moerman, J. Lauweryns, and E. Eggermont. 1991. Different patterns of pulmonary sequelae after hyaline membrane disease: heterogeneity of bronchopulmonary dysplasia. Biol. Neonate 60:152-162.
33. Husain, A., N. Siddiqui, and J. Stocker. 1998. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum. Pathol. 29:710-717.
34. Thurlbeck, W. M. 1982. Postnatal human lung growth. Thorax 37:564-571.
35. Burri, P. H., editor. 1997. Structural aspects of prenatal and postnatal development and growth of the lung. In Lung Growth and Development. Marcel Dekker, New York.
36. Becker, M. J., and J. G. Koppe. 1969. Pulmonary structural changes in neonatal hyaline membrane disease treated with high pressure artificial respiration. Thorax 24:689-694.
37. Anderson, W., and M. Strickland. 1971. Pulmonary complications of oxygen therapy in the neonate: postmortem study of bronchopulmonary dysplasia with emphasis on fibroproliferative obliterative bronchitis and bronchiolitis. Arch. Pathol. 91:506-514.
38. Bonikos, D. S., K. G. Bensch, W. H. Northway, and D. K. Edwards. 1976. Bronchopulmonary dysplasia: the pulmomary pathogenic sequel of necrotizing bronchiolitis and pulmonary fibrasis. Hum. Pathol. 7:643-666.
39. Taghizadeh, A., and F. O. R. Reynolds. 1976. Pathogenesis of bronchopulmonary dysplasia following hyaline membrane disease. Am. J. Pathol. 82:241-258.
40. Loosli, C., and E. Potter. 1959. Pre- and postnatal development of the respiratory portion of the human lung. Am. Rev. Respir. Dis. 80:5-23.
41. Fukuda, Y. V. Ferrans, and R. Crystal. 1983, The development of alveolar septa in fetal sheep lung: an ultrastructural and immunohistochemical study. Am. J. Anat. 167:405-439.
42. Noguchi, A., K. Firsching, J. Kursar, and R. Reddy. 1991. Developmental changes in tropoelastin gene expression in the rat lung studied by in situ hybridization. Am. J. Respir. Cell Mol. Biol. 1991:571-578.
43. Roman, J., editor. 1997. Cell-cell and cell-matrix interactions in development of the lung vasculature. In Lung Growth and Development. Marcel Dekker, New York.
44. Groneck, P., B. Gotze-Speer, M. Oppermann, H. Effect, and C. P. Speer. 1994. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 93:712-718.
45. Pierce, M., and E. Bancalari. 1995. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Pediatr. Pulmonol. 19:371-378.
46. Zimmermann, J. 1995. Bronchoalvcolar inflammatory pathophysiology of bronchopulmonary dysplasia. Clin. Perinatol. 22:429-456.
47. Merritt, T. A., J. M. Puccia, and I. D. Stuard 1981. Cytologic evaluation of pulmonary effluent in neonates with respiratory distress syndrome and bronchopulmonary dysplasia. Acta Cytol. 25:631-639.
48. Ogden, B., S. Murphy, G. Saunders, D. Pathak, and J. Johnson. 1984. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am. Rev. Respir. Dis. 130:817-821.
49. Sherman, M., E. Goldstein, W. Lippert, and R. Wennberg. 1977. Neonatal lung defense mechanisms: a study of the alveolar macrophage system in neonatal rabbits. Am. Rev. Respir. Dis. 116:433-440.
50. Bellanti, J., L. Nerurkar, and B. Zeligs. 1979. Host defenses in the fetus and neonate: studies of the alveolar macrophage during maturation. Pediatrics 64:726-739.
51. Alenghat, E., and J. Esterly 1984. Alveolar macrophages in perinatal infants. Pediatrics 74:221-223.
52. Kurland, G., A. Cheung, M. Miller, S. Ayin, M. Cho, and E. Ford. 1988. The ontogeny of pulmonary defenses: alveolar macrophage function in neonatal and juvenile rhesus monkeys. Pediatr. Res. 23:293-297.
53. Jacobs, R. F., C. B. Wilson, and S. Palmer. 1985. Factors related to the appearance of alveolar macrophages in the developing lung. Am. Rev. Respir. Dis. 131:548-553.
54. Arnon, S., J. Grigg, and M. Silverman. 1993. Pulmonary inflammatory cells in ventilated preterm infants: effect of surfactant treatment. Arch. Dis. Child. 69:44-48.
55. Rindfleisch, M., J. Hasday, V. Taciak, K. Broderick, and R. Viscardi. 1996. Potential role of interleukin-1 in the development of bronchopulmonary dysplasia. J. Interferon Cytokine Res. 16:365-373.
56. Groneck, P., and C. Speer. 1995. Inflammatory mediators and bronchopulmonary dysplasia. Arch. Dis. Child. 73:F1-F3.
57. Kotecha, S. 1996. Cytokines in chronic lung disease of prematurity. Eur. J. Pediatr. 155(Suppl. 2):514-517.
58. Tullus, K., G. Noack, L. Burman, R. Nilsson, B. Wretlind, and A. Brauner. 1996. Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur. J. Pediatr. 155:112-116.